<code id='23CDB85BE6'></code><style id='23CDB85BE6'></style>
    • <acronym id='23CDB85BE6'></acronym>
      <center id='23CDB85BE6'><center id='23CDB85BE6'><tfoot id='23CDB85BE6'></tfoot></center><abbr id='23CDB85BE6'><dir id='23CDB85BE6'><tfoot id='23CDB85BE6'></tfoot><noframes id='23CDB85BE6'>

    • <optgroup id='23CDB85BE6'><strike id='23CDB85BE6'><sup id='23CDB85BE6'></sup></strike><code id='23CDB85BE6'></code></optgroup>
        1. <b id='23CDB85BE6'><label id='23CDB85BE6'><select id='23CDB85BE6'><dt id='23CDB85BE6'><span id='23CDB85BE6'></span></dt></select></label></b><u id='23CDB85BE6'></u>
          <i id='23CDB85BE6'><strike id='23CDB85BE6'><tt id='23CDB85BE6'><pre id='23CDB85BE6'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:3275
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          It's time to retire 'poor historian' from clinicians' vocabularies
          It's time to retire 'poor historian' from clinicians' vocabularies

          AdobeShouldwepitythe“poorhistorians”—theindividualsorfamilymemberswhocan’tgiveaclearaccountingofthei

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          AI generated plenty of interest at JPM but not a lot of trust

          AdobeYoudidn’tneedmachinelearningtomakeonepredictionabouttheyear’sbiggestconferenceforhealthcareinve